Measurement of alkaline phosphatase levels in body fluids

• US 4,059,490 A
• Filed: 09/10/1976
• Issued: 11/22/1977
• Est. Priority Date: 09/22/1975
• Status: Expired due to Term

• Current Assignee: Chembro Holdings Limited
• Original Assignee: Chembro Holdings Limited
• Inventors: Donninger, Cyril, Axcell, Barry Clifford
• Primary Examiner(s): Tanenholtz, Alvin E.
• Assistant Examiner(s): Fan, C. A.
• Application Number:
  US05/722,240
• Time in Patent Office: 438 Days
• Field of Search: 195/103.5 R, 195/99, 195/127, 204/1 E
• US Class Current: 205/777.5
• CPC Class Codes: C12Q 1/42 involving phosphatase
• CPC Class Codes: C12Q 2334/00 O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
• CPC Class Codes: Y10S 435/817 Enzyme or microbe electrode

Abstract

A method of measuring the alkaline phosphatase level in a body fluid such as serum or plasma comprising hydrolyzing excess monophosphate ester dissolved in a suitable buffer by action of alkaline phosphatase in a predetermined volume of the body fluid to yield an oxidizable substrate, oxidizing the substrate with excess molecular oxygen in the presence of excess oxygenase and measuring the rate of oxygen consumption, preferably by means of an oxygen electrode. The invention also provides a reagent for use in this method which comprises a diethanolamine-HCl buffer having a molarity of 0.1 M to 4.0 M and a pH of 8.6 to 10.8 and containing magnesium ions in a concentration of 100 to 1000 μM and an excess of oxygenase.

Claims

1. A method of measuring the alkaline phosphatase level in a body fluid comprising hydrolysing excess monophosphate ester dissolved in a suitable buffer by action of the alkaline phosphatase in a predetermined volume of the body fluid to yield an oxidisable substrate, said ester being a catechol monophosphate ester which may have one or more ring substituents, oxidizing the substrate with excess molecular oxygen in the presence of excess oxygenase and measuring the rate of oxygen comsumption.

2. A method according to claim 1 wherein the rate of oxygen consumption is measured using an oxygen electrode.

3. A method according to claim 1 wherein the oxygenase is polyphenol oxidase.

4. A method according to claim 1 wherein the buffer is a diethanolamine-HCl buffer having a molarity of 0.1 M to 4.0 M and a pH of 8.6 to 10.8.

5. A method according to claim 4 wherein the buffer has a molarity of 2.0 to 2.5 M and a pH of 9.8 to 9.9.

6. A method according to claim 4 wherein the buffer contains magnesium ions in a concentration of 100 to 1000 μ

M.

11. A reagent for use in the method of claim 1 comprising a diethanolamine-HCl buffer having a molarity of 0.1 M to 4.0 M and a pH of 8.6 to 10.8 and containing magnesium ions in a concentration of 100 to 1000 μ

M and an excess of oxygenase.

12. A reagent according to claim 11 wherein the buffer has a molarity of 2.0 to 2.5 M and a pH of 9.8 to 9.9.

13. A reagent according to claim 11 wherein the oxygenase is polyphenol oxidase.

14. A diagnostic kit for use in the method of claim 1 comprising

a. a container containing diethanolamine-HCl buffer of pH 8.6 to 10.8 and molarity 0.1 M to 4.0 M and containing 100 μ

M to 1000 μ

M magnesium ions;

b. a container containing polyphenol oxidase in a tris(hydroxymethyl)aminomethane-HCl buffer of pH 7.5 and molarity not exceeding one percent of the molarity of the buffer of (a);

c. a container containing a salt of catechol monophosphate; and

d. a container containing tris(hydroxymethyl)aminomethane-HCl buffer of pH 7.0 and molarity not exceeding one percent of the molarity of the buffer of (a).

15. A kit according to claim 14 wherein the buffer of (a) has a molarity of 2.0 M to 2.5 M and a pH of 9.8 to 9.9.

7. A method of measuring the alkaline phosphatase level in a body fluid comprising hydrolysing excess catechol monophosphate dissolved in a diethanolamine-HCl buffer having a molarity of 0.1 M to 4.0 M and a pH of 8.6 to 10.8 and containing magnesium ions in a concentration of 100 μ

M to 1000 μ

M by action of the alkaline phosphatase in a predetermined volume of the body fluid to yield catechol, oxidising the catechol and excess molecular oxygen in the presence of excess polyphenol oxidase and measuring the rate of oxygen consumption using an oxygen electrode.

8. A method according to claim 7 wherein the buffer has a molarity of 2.0 M to 2.5 M and a pH of 9.8 to 9.9.

9. A method according to claim 7 wherein the body fluid is selected from plasma and serum.

10. A method according to claim 8 wherein the body fluid is selected from plasma and serum.